These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Olsson B; Lautner R; Andreasson U; Öhrfelt A; Portelius E; Bjerke M; Hölttä M; Rosén C; Olsson C; Strobel G; Wu E; Dakin K; Petzold M; Blennow K; Zetterberg H Lancet Neurol; 2016 Jun; 15(7):673-684. PubMed ID: 27068280 [TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study. Dhiman K; Villemagne VL; Fowler C; Bourgeat P; Li QX; Collins S; Bush AI; Rowe CC; Masters CL; Ames D; Blennow K; Zetterberg H; Martins RN; Gupta V Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625782 [TBL] [Abstract][Full Text] [Related]
27. Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults. Blackman J; Stankeviciute L; Arenaza-Urquijo EM; Suárez-Calvet M; Sánchez-Benavides G; Vilor-Tejedor N; Iranzo A; Molinuevo JL; Gispert JD; Coulthard E; Grau-Rivera O; Brain Commun; 2022; 4(6):fcac257. PubMed ID: 36337343 [TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples. Skillbäck T; Zetterberg H; Blennow K; Mattsson N Alzheimers Res Ther; 2013 Oct; 5(5):47. PubMed ID: 24479774 [TBL] [Abstract][Full Text] [Related]
29. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
30. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease. Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M; JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873 [TBL] [Abstract][Full Text] [Related]
31. Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment. Giacomucci G; Mazzeo S; Bagnoli S; Ingannato A; Leccese D; Berti V; Padiglioni S; Galdo G; Ferrari C; Sorbi S; Bessi V; Nacmias B J Neurol; 2022 Aug; 269(8):4270-4280. PubMed ID: 35288777 [TBL] [Abstract][Full Text] [Related]
32. Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individuals. Alemany S; Crous-Bou M; Vilor-Tejedor N; Milà-Alomà M; Suárez-Calvet M; Salvadó G; Cirach M; Arenaza-Urquijo EM; Sanchez-Benavides G; Grau-Rivera O; Minguillon C; Fauria K; Kollmorgen G; Domingo Gispert J; Gascón M; Nieuwenhuijsen M; Zetterberg H; Blennow K; Sunyer J; Luis Molinuevo J; Environ Int; 2021 Dec; 157():106864. PubMed ID: 34537521 [TBL] [Abstract][Full Text] [Related]
33. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression. Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131 [TBL] [Abstract][Full Text] [Related]
34. Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers. Novobilský R; Bartova P; Lichá K; Bar M; Stejskal D; Kusnierova P Front Hum Neurosci; 2023; 17():1284416. PubMed ID: 38164192 [TBL] [Abstract][Full Text] [Related]
35. Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg. Dittrich A; Ashton NJ; Zetterberg H; Blennow K; Zettergren A; Simrén J; Skillbäck T; Shams S; Machado A; Westman E; Schöll M; Skoog I; Kern S Neurology; 2023 Jul; 101(3):e277-e288. PubMed ID: 37225431 [TBL] [Abstract][Full Text] [Related]
36. Novel Biomarkers for Alzheimer's Disease: Plasma Neurofilament Light and Cerebrospinal Fluid. Abukuri DN Int J Alzheimers Dis; 2024; 2024():6668159. PubMed ID: 38779175 [TBL] [Abstract][Full Text] [Related]
37. The dynamics of plasma biomarkers across the Alzheimer's continuum. Guo Y; Shen XN; Wang HF; Chen SD; Zhang YR; Chen SF; Cui M; Cheng W; Dong Q; Ma T; Yu JT Alzheimers Res Ther; 2023 Feb; 15(1):31. PubMed ID: 36750875 [TBL] [Abstract][Full Text] [Related]
38. Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers. Mielke MM; Przybelski SA; Lesnick TG; Kern S; Zetterberg H; Blennow K; Knopman DS; Graff-Radford J; Petersen RC; Jack CR; Vemuri P Alzheimers Dement; 2021 May; 17(5):801-812. PubMed ID: 33663022 [TBL] [Abstract][Full Text] [Related]
39. CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly. Shue F; White LJ; Hendrix R; Ulrich J; Henson RL; Knight W; Martens YA; Wang N; Roy B; Starling SC; Ren Y; Xiong C; Asmann YW; Syrjanen JA; Vassilaki M; Mielke MM; Timsina J; Sung YJ; Cruchaga C; Holtzman DM; Bu G; Petersen RC; Heckman MG; Kanekiyo T Sci Adv; 2024 Apr; 10(14):eadk3674. PubMed ID: 38569027 [TBL] [Abstract][Full Text] [Related]
40. Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition. Tideman P; Stomrud E; Leuzy A; Mattsson-Carlgren N; Palmqvist S; Hansson O; Neurology; 2022 Apr; 98(15):e1525-e1533. PubMed ID: 35022305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]